The short-term effects of growth hormone therapy on height velocity and cardiac ventricular wall thickness in children with Noonan's syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 6, 1996, Pages 2291-2297

  Cotterill, Andrew M ^a   Mckenna, William J ^b   Brady, Angela F ^b   Sharland, Michael ^b   Elsawi, Medeha ^b   Yamada, Mitsutoshi ^b   Camacho hübner, Cecilia ^a   Kelnar, Christopher J H ^c   Dunger, David B ^d   Patton, Michael A ^b   Savage, Martin O ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GROWTH HORMONE; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GROWTH RATE; HEART PAPILLARY MUSCLE; HEART VENTRICLE HYPERTROPHY; HUMAN; MALE; MITRAL VALVE; MULTICENTER STUDY; NOONAN SYNDROME; PREPUBERTY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADOLESCENT; BODY HEIGHT; BODY MASS INDEX; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; FEMALE; GROWTH HORMONE; HEART VENTRICLES; HUMANS; MALE; MYOCARDIUM; NOONAN SYNDROME; RECOMBINANT PROTEINS; SKINFOLD THICKNESS; TIME FACTORS; TREATMENT FAILURE;

EID: 8944253298     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.6.2291     Document Type: Article

References (36)

1. Noonan J, Ehmke DA. 1963 Associated non-cardiac malformations in children with congenital heart disease. J Pediatr. 63:468-470.
2. Mendez HMM, Optiz JM. 1985 Noonan syndrome: a review. Am J Med Genet. 21:493-506.
3. Allanson JE. 1987 Noonan syndrome. J Med Genet. 24:9-13.
4. Sharland M, Burch M, McKenna WJ, Patton MA. 1992 A clinical study of Noonan syndrome. Arch Dis Child. 67:178-183.
5. Burch M, Sharland M, Shinebourne E, Smith G, Patton MA, McKenna WJ. 1993 Cardiological abnormalities in Noonan syndrome: phenotypic diagnosis and echocardiographic assessment of 118 patients. J Am Coll Cardiol. 22: 1189-1192.
6. Sharland M, Patton MA, Talbot S, Chitolie A, Bevan DH. 1992 Coagulation-factor deficiencies and abnormal bleeding in Noonan's syndrome. Lancet. 339:19-21.
7. Caralis DG, Char F, Graber JD, Voigt GC. 1974 Delineation of multiple cardiac anomalies associated with the Noonan's syndrome in an adult and review of the literature. Johns Hopkins Med J. 134:346-353.
8. Allanson JE, Hall JG, Hughes HE, Preus M, Witt RD. 1985 Noonan syndrome: the changing phenotype. Am J Med Genet. 21:507-514.
9. Sharland M, Morgan M, Patton MA. 1993 Photoanthropometric study of facial growth in Noonan syndrome. Am J Med Genet. 45:430-436.
10. Duncan WJ, Fowler RS, Farkes LG. 1981 A comprehensive scoring system for evaluating Noonan syndrome. Am J Med Genet. 10:37-50.
11. Witt DR, Kenna BA, Hall JG, Allanson JE. 1986 Growth curves for height in Noonan syndrome. Clin Genet. 30:150-153.
12. Ranke M, Heidemann P, Knupfer C, Enders H, Schmaltz AA, Bierich JR. 1988 Noonan syndrome: growth and clinical manifestations in 144 cases. Eur J Pediatr. 148:220-227.
13. Elders MJ, Char F. 1976 Possible etiologic mechanisms of the short stature in the Noonan syndrome. National Foundation of Birth Defects, Original Article Series. 12:127-133.
14. Spadoni GL, Bernardini S, Cianfarani S. 1990 Spontaneous growth hormone secretion in Noonan's syndrome. Acta Paediatr Scand. 367(Suppl):157.
15. Ahmed ML, Foot AB, Edge JA, Lamkin VA, Savage MO, Dunger DB. 1991 Noonan's syndrome: abnormalities of the growth hormone/IGF-I axis and the response to treatment with human biosynthetic growth hormone. Acta Paediatr Scand. 80(Suppl):446-50.
16. Tanaka K, Sato A, Naito T, Kuramochi K, Itabashi H, Takemura Y. 1992 Noonan syndrome presenting with growth hormone neurosecretory dysfunction. Intern Med. 31:908-911.
17. Rosenfeld RG, Frane J, Attie KM, et al. 1992 Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome. J Pediatr. 121:49-55.
18. Thomas BC. Stanhope R. 1993 Long-term treatment with growth hormone in Noonan's syndrome. Acta Paediatr Scand. 82:853-855.
19. Tanner JM, Whitehouse RH, Cameron N, Marshall WA, Healy MJR, Goldstein H. 1983 The assessment of skeletal maturity and prediction of adult height (TW2 method). London: Academic Press; 90, 94.
20. Freeman JV, Cole TJ, Chinn S, Jones PRM, White EM, Preece MA. 1995 Cross-sectional stature and weight reference curves for the UK, 1990. Arch Dis Child. 73:17-24.
21. Cole TJ, Freeman JV, Preece MA. 1995 Body mass index reference curves for the UK, 1990. Arch Dis Child. 73:25-29.
22. Tanner JM, Whitehouse RH, Takaishi M. 1966 Standards from birth to maturity for height, weight, height velocity and weight velocity: British children, 1965. Arch Dis Child. 41:454-471, 613-635.
23. Rautaharju PM, Davignon A, Soumis F, Boiselle E, Choquette A. 1979 Evolution of QRS-T relationship from birth to adolescence in Frank-lead orthogonal electrocardiograms of 1492 normal children. Circulation. 60:196-204.
24. Shapiro LM, McKenna WJ. 1983 Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two dimensional echocardiographic study. J Am Coll Cardiol. 2:437-444.
25. Holly JMP, Biddlecombe RA, Dunger DB, et al. 1988 Circadian variation of GH-dependent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin? Clin Endocrinol (Oxf). 29:667-675.
26. Blum WF, Ranke MB, Bierich JR. 1988 A specific radioimmunoassay for insulin-like growth factor-II: the interference of the insulin-like growth factor binding proteins can be blocked by excess insulin-like growth factor-I. Acta Endocrinol (Copenh). 118:374-380.
27. Ward KA, Moss C, McKeown C. 1994 The cardio-facio-cutaneous syndrome: a manifestation of the Noonan syndrome? Br J Dermatol. 131:270-274.
28. Shailand M, Taylor R, Patton MA, Jeffery S. 1992 Absence of linkage of Noonan syndrome to the neurofibromatosis type 1 locus. J Med Genet. 29: 188-190.
29. Stern HJ, Saal HM, Lee JS, et al. 1992 Clinical variability of type 1 neurofibromatosis: is there a neurofibromatosis-Noonan syndrome? J Med Genet. 29:184-187.
30. Neri G, Zollino M, Reynolds JF. 1991 The Noonan-CFC controversy. Am J Med Genet. 39:367-370.
31. Fryer AE, Holt PJ, Hughes HE. 1991 The cardio-facio-cutaneous (CFC) syndrome and Noonan syndrome: are they the same? Am J Med Genet. 38:548-551.
32. Jamieson CR, van der Burgt I, Brady AF, et al. 1994 Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nature Genet. 8:357-360.
33. Van der Burgt I, Berends E, Lommen E, van Beersum S, Hamel B, Mariman E. 1994 Clinical and molecular studies in a large Dutch family with Noonan syndrome. Am J Med Genet. 53:187-191.
34. Elsawi MM, Pryor JP, Klufio G, Barnes C, Patton MA. 1994 Genital tract function in men with Noonan syndrome. J Med Genet. 31:468-470.
35. Theintz G, Savage MO. 1982 Growth and pubertal development in five boys with Noonan's syndrome. Arch Dis Child. 57:13-17.
36. Burch M, Mann JM, Sharland M, Shinebourne EA, Patton MA, McKenna WJ. 1992 Myocardial disarray in Noonan syndrome. Br Heart J. 68:586-588.